Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02158975 · OUTCOME

Median Overall Survival Time

Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas · Source last updated 2017-11-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
months
Interval / dispersion
95% Confidence Interval
Time frame
24 months after initiation of study treatment

What was measured

Overall Survival (OS) is defined as the time from study start until death.

Analysis population: Five patients died between start of treatment and database lock. Patients who were alive at the time of the database lock (March 31st, 2017) were administratively censored.

Groups in this outcome

MLN9708

MLN9708 4mg by mouth weekly (days 1, 8, 15) every 28 days. MLN9708

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
MLN970812

Reported measurements

Source class 1
Values in months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
MLN9708NANot reported8.1NAThe median overall survival time at 24 months could not be estimated. The lower bound of the 95% confidence interval was 8.1 months.
Complete source fields
classes
  1. categories
    1. measurements
      1. comment
        The median overall survival time at 24 months could not be estimated. The lower bound of the 95% confidence interval was 8.1 months.
        group Id
        OG000
        lower Limit
        8.1
        upper Limit
        NA
        value
        NA
denoms
  1. counts
    1. group Id
      OG000
      value
      12
    units
    Participants
description
Overall Survival (OS) is defined as the time from study start until death.
dispersion Type
95% Confidence Interval
groups
  1. description
    MLN9708 4mg by mouth weekly (days 1, 8, 15) every 28 days. MLN9708
    id
    OG000
    title
    MLN9708
param Type
MEDIAN
population Description
Five patients died between start of treatment and database lock. Patients who were alive at the time of the database lock (March 31st, 2017) were administratively censored.
reporting Status
POSTED
time Frame
24 months after initiation of study treatment
title
Median Overall Survival Time
type
SECONDARY
unit Of Measure
months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice